Skip to main content
. Author manuscript; available in PMC: 2017 Nov 13.
Published in final edited form as: Pharmacol Biochem Behav. 2016 Nov 13;150-151:198–206. doi: 10.1016/j.pbb.2016.11.003

Fig. 3.

Fig. 3

N-phenylpropyl-N´-substituted piperazine sigma receptor ligands do not inhibit [125I]RTI-121 specific binding to DAT in vivo at 30 min in mouse brain. The DAT inhibitor GBR-12909 was also examined (10 µmol/kg) and asterisks designate a significant (p < 0.05) difference from the control group.